Related Experiment Videos
Distraction osteogenesis for cleft palate closure in a canine model
Robert J Tibesar1, Eric J Moore, Uldis Bite
1Department of Otorhinolaryngology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Archives of Facial Plastic Surgery
|November 23, 2005
Summary
Distraction osteogenesis (DO) is a safe technique for closing hard palate clefts in dogs, achieving complete bone closure in most cases. Further research is recommended for its application in human cleft palate treatment.
Area of Science:
- Veterinary Surgery
- Craniofacial Surgery
- Regenerative Medicine
Background:
- Cleft palate is a common congenital condition requiring surgical intervention.
- Traditional surgical repair of palatal defects can be challenging, especially in complex cases.
- Distraction osteogenesis (DO) offers a method for gradual bone lengthening and defect closure.
Purpose of the Study:
- To evaluate the effectiveness and safety of distraction osteogenesis (DO) for closing surgically created hard palate clefts in a canine model.
- To assess the potential of DO as an alternative or adjunct to conventional surgical techniques for palatal reconstruction.
Main Methods:
- A midline hard palate cleft was surgically created in 10 mature dogs.
- Eight dogs received customized DO devices for gradual bone distraction at 1 mm/day after a 10-day latency period.
- Bone healing was analyzed using fluorochrome labeling and traditional histology following a 14-day consolidation period.
Main Results:
- Distraction osteogenesis was well-tolerated, with no serious complications reported in the experimental group.
- Complete bony closure of the hard palate cleft was achieved in 5 out of 8 dogs treated with DO.
- Bone resorption and incomplete closure were observed in 3 dogs, as well as in the two control dogs without distraction.
Conclusions:
- Distraction osteogenesis is a safe and feasible technique for addressing hard palate clefts in a canine model.
- DO demonstrated efficacy in achieving bony closure of palatal defects in a significant portion of the treated dogs.
- The findings support further investigation into the innovative application of DO for treating human cleft palate patients.